name	nt_name	aa_name	multi_aa_name	multiaa_mutation_split_names	start	vcf_gene	chrom_region	mutation_type	dp	obs_sample_size	variant_pop_size	ps_filter	ps_exc	mat_pep_id	mat_pep_desc	mat_pep_acc	ro	ao_by_var_seq	ao	variant_seq	reference_seq	function_category	citation	citation_url	comb_mutation	function_description	heterozygosity	viral_lineages	clade_defining_status	status	voi_designation_date	voc_designation_date	vum_designation_date
A119P	g.G355C	p.A119P			28628	N	N	MISSENSE	30	30	0						29	C=1	1	C	G						False	C.37	C.37=False	de_escalated	14-Jun-2021		
A2S	g.G4T	p.A2S			26526	M	M	MISSENSE	30	30	0						29	T=1	1	T	G	immunosuppression variant emergence	Avanzato et al. (2020)	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640888/		Emergent as 16% variant by day 70 post-infection of female immunocompromised  individual with chronic lymphocytic leukemia and acquired hypogammaglobulinemia.  Variant became 100% in day 70 culture. Variant disappeared after convalescent plasma treatment (day 71) in subsequent patient sample sequencing.	False	C.37	C.37=False	de_escalated	14-Jun-2021		
A5026A	g.C15078T	p.A5026A			15342	ORF1ab	ORF1b	SILENT	30	30	0			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only		29	T=1	1	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
A5703A	g.C17109T	p.A5703A			17373	ORF1ab	ORF1b	SILENT	30	30	0			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only		11	T=19	19	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
A690V	g.C2069T	p.A690V			2334	ORF1ab	ORF1a	MISSENSE	30	30	0			nsp2	produced by both pp1a and pp1ab		29	T=1	1	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
D103H	g.G307C	p.D103H			28580	N	N	MISSENSE	30	30	0						29	C=1	1	C	G						False	C.37	C.37=False	de_escalated	14-Jun-2021		
D3492D	g.C10476T	p.D3492D			10741	ORF1ab	ORF1a	SILENT	28	30	0			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab		27	T=1	1	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
D3508D	g.C10524T	p.D3508D			10789	ORF1ab	ORF1a	SILENT	28	30	0			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab		27	T=1	1	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
D614G	g.A1841G	p.D614G			23403	S	S	MISSENSE	30	30	0						0	G=30	30	G	A	ACE2 receptor binding affinity	Li et al. (2020)	https://doi.org/10.1016/j.cell.2020.07.012		In four cell lines (including 293T-hACE2 cells), this mutation combination increases infectivity vs D614G alone	False	C.37	C.37=True	de_escalated	14-Jun-2021		
D614G	g.A1841G	p.D614G			23403	S	S	MISSENSE	30	30	0						0	G=30	30	G	A	immunosuppression variant emergence	Landis et al. (2021)	https://www.medrxiv.org/content/10.1101/2021.05.08.21256775v1		Studying 94 COVID-19 extended infection cases with genomics April 1 to October 17, 2020, one case developed 23 mutations in a 19 day period, including this combination in Spike.	False	C.37	C.37=True	de_escalated	14-Jun-2021		
D614G	g.A1841G	p.D614G			23403	S	S	MISSENSE	30	30	0						0	G=30	30	G	A	syncytium formation	Kim et al. (2021)	https://dx.doi.org/10.3390%2Fv13040633		Slight increase in Vero cell-cell membrane fusion assay under infection with VSV pseudotyped virus.	False	C.37	C.37=True	de_escalated	14-Jun-2021		
D614G	g.A1841G	p.D614G			23403	S	S	MISSENSE	30	30	0						0	G=30	30	G	A	tissue specific neutralization	Planas et al. (2021)	https://www.nature.com/articles/s41591-021-01318-5		The nasal mucosa of Pfizer vaccinees with time course collection was evaluated against VSV pseudotypes: results (only one nasal  swab from different previously infected vacinee neutralizing at weeks 3 and 6 against B.1.1.7 and D614G) suggest that vaccinees probably  do not elicit an early humoral response detectable at mucosal surfaces even though sera neutralization was observed. They strengthen the hypothesis that some vaccines may not protect against  viral acquisition and infection of the oral–nasal region, but may prevent severe disease associated with viral dissemination in the lower respiratory tract. 	False	C.37	C.37=True	de_escalated	14-Jun-2021		
D614G	g.A1841G	p.D614G			23403	S	S	MISSENSE	30	30	0						0	G=30	30	G	A	trafficking	Barrett et al. (2021)	https://www.biorxiv.org/content/10.1101/2021.01.24.428007v1		Circulating variant shown in vitro to not have major defects or enhancement of cell surface protein trafficking (i.e. Spike cleavage or fusion required for cell entry)	False	C.37	C.37=True	de_escalated	14-Jun-2021		
D614G	g.A1841G	p.D614G			23403	S	S	MISSENSE	30	30	0						0	G=30	30	G	A	trafficking	Daniloski et al. (2021)	https://doi.org/10.7554/elife.65365		The increased transduction with Spike D614G ranged from 1.3- to 2.4-fold in Caco-2 and Calu-3 cells expressing  endogenous ACE2 and from 1.5- to 7.7-fold in A549ACE2 and Huh7.5ACE2 overexpressing ACE2.  Although there is minimal difference in ACE2 receptor binding between the D614 and G614 Spike variants,  the G614 variant is more resistant to proteolytic cleavage, suggesting a possible mechanism for the increased transduction.	False	C.37	C.37=True	de_escalated	14-Jun-2021		
D614G	g.A1841G	p.D614G			23403	S	S	MISSENSE	30	30	0						0	G=30	30	G	A	trafficking	Kim et al. (2021)	https://dx.doi.org/10.3390%2Fv13040633		No change in infectivity (24h) relative to D614G alone in Caco-2 cells, Vero or Calu-3.	False	C.37	C.37=True	de_escalated	14-Jun-2021		
D614G	g.A1841G	p.D614G			23403	S	S	MISSENSE	30	30	0						0	G=30	30	G	A	trafficking	Kim et al. (2021)	https://dx.doi.org/10.3390%2Fv13040633		~4x more efficient S2 domain cleavage compared to wild type in Caco-2 cells, mid-range of three cell line tested (Vero and Calu-3).	False	C.37	C.37=True	de_escalated	14-Jun-2021		
D614G	g.A1841G	p.D614G			23403	S	S	MISSENSE	30	30	0						0	G=30	30	G	A	trafficking	Ozono et al. (2020)	https://www.nature.com/articles/s41467-021-21118-2		Among S variants tested, the D614G mutant shows the highest cell entry (~3.5x wild type), as supported by  structural and binding analyses. 	False	C.37	C.37=True	de_escalated	14-Jun-2021		
D614G	g.A1841G	p.D614G			23403	S	S	MISSENSE	30	30	0						0	G=30	30	G	A	trafficking	Zhang et l. (2020)	https://www.nature.com/articles/s41467-020-19808-4		We report here pseudoviruses carrying SG614 enter ACE2-expressing cells more efficiently than wild type (~9-fold).  This increased entry correlates with less S1-domain shedding and higher S-protein incorporation into the virion.  D614G does not alter S-protein binding to ACE2 or neutralization sensitivity of pseudoviruses. Thus, D614G may  increase infectivity by assembling more functional S protein into the virion.	False	C.37	C.37=True	de_escalated	14-Jun-2021		
D614G	g.A1841G	p.D614G			23403	S	S	MISSENSE	30	30	0						0	G=30	30	G	A	vaccine neutralization efficacy	Garcia-Beltran et al. (2021)	https://doi.org/10.1016/j.cell.2021.03.013		Pseudotyped D614G virus has reduced neutralization activity vs wild type: 1.2x (37 sera Pfizer median 9  days post 2nd dose, 37 sera Moderna median 18 days post 2nd dose). This was NOT significant by ANOVA.	False	C.37	C.37=True	de_escalated	14-Jun-2021		
D614G	g.A1841G	p.D614G			23403	S	S	MISSENSE	30	30	0						0	G=30	30	G	A	vaccine neutralization efficacy	Kuzmina et al. (2021)	https://dx.doi.org/10.1016%2Fj.chom.2021.03.008		Using a lentivirus virus pseudotyped with D614G Spike, sera from vaccinated individuals who received the second dose (9–11 days post-second dose of Pfizer) exhibited a robust  neutralizing potential, with a mean NT50 value of 99,000. This was an average of a 2-fold increase, relative to sera drawn from the  individuals who received one dose of vaccination—mean NT50 dilution of 51,300. Importantly, a 6-fold increase in mean NT50 dilution was  obtained when sera from the first vaccination dose was compared to convalescent sera from cohort with severe disease (NT50 51,000 vs 8,700)  21 to 63 days post-onset. 	False	C.37	C.37=True	de_escalated	14-Jun-2021		
D614G	g.A1841G	p.D614G			23403	S	S	MISSENSE	30	30	0						0	G=30	30	G	A	viral load	Plante et al. (2020)	https://www.nature.com/articles/s41586-020-2895-3		Hamsters infected with SARS-CoV-2 expressing spike(D614G) (G614 virus) produced higher infectious titres in nasal washes and the trachea, but not in the lungs,  supporting clinical evidence showing that the mutation enhances viral loads in the upper respiratory tract of COVID-19 patients and may increase transmission.	False	C.37	C.37=True	de_escalated	14-Jun-2021		
D614G	g.A1841G	p.D614G			23403	S	S	MISSENSE	30	30	0						0	G=30	30	G	A	virion structure	Spratt et al. (2021)	https://www.biorxiv.org/content/10.1101/2021.03.24.436850v1		Estimated free energy change (ddG) for this variant is 2.5 kcal/mol (i.e. stabilizing relative to wild type) 	False	C.37	C.37=True	de_escalated	14-Jun-2021		
D614G	g.A1841G	p.D614G			23403	S	S	MISSENSE	30	30	0						0	G=30	30	G	A	virion structure	Weissman et al. (2020)	https://www.medrxiv.org/content/10.1101/2020.07.22.20159905v2		"Negative stain EM shows increased proportion of ""one-up"" trimer conformation of Spike proteins on the surface of virions, where the up  conformation is presumed to be more likely to bind ACE2."	False	C.37	C.37=True	de_escalated	14-Jun-2021		
D614G	g.A1841G	p.D614G			23403	S	S	MISSENSE	30	30	0						0	G=30	30	G	A	virion structure	Yurkovetskiy et al. (2020)	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492024/		"CryoEM shows increased proportion of ""one-up"" trimer conformation of Spike proteins on the surface of virions, where the up  conformation is presumed to be more likely to bind ACE2."	False	C.37	C.37=True	de_escalated	14-Jun-2021		
D614G	g.A1841G	p.D614G			23403	S	S	MISSENSE	30	30	0						0	G=30	30	G	A	virion structure	Zhang et al. (2020)	https://www.nature.com/articles/s41467-020-19808-4		Based on pseudotyped virus experiments, D614G may increase infectivity by assembling more functional S protein into the virion.	False	C.37	C.37=True	de_escalated	14-Jun-2021		
E159A	g.A476C	p.E159A			741	ORF1ab	ORF1a	MISSENSE	30	30	0			leader protein	nsp1, produced by both pp1a and pp1ab		29	C=1	1	C	A						False	C.37	C.37=False	de_escalated	14-Jun-2021		
E5568A	g.A16703C	p.E5568A			16967	ORF1ab	ORF1b	MISSENSE	30	30	0			helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only		29	C=1	1	C	A						False	C.37	C.37=False	de_escalated	14-Jun-2021		
F120F	g.C360T	p.F120F			28253	ORF8	ORF8	SILENT	30	30	0	mask	highly_homoplasic				0	T=30	30	T	C						False	C.37	C.37=True	de_escalated	14-Jun-2021		
F2387V	g.T7159G	p.F2387V			7424	ORF1ab	ORF1a	MISSENSE	30	30	0			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab		0	G=30	30	G	T						False	C.37	C.37=True	de_escalated	14-Jun-2021		
F346F	g.C1038T	p.F346F			29311	N	N	SILENT	30	30	0						0	T=30	30	T	C						False	C.37	C.37=True	de_escalated	14-Jun-2021		
F490S	g.T1469C	p.F490S			23031	S	S	MISSENSE	30	30	0						0	C=30	30	C	T	ACE2 receptor binding affinity	Zahradnik et al. (2021)	https://www.biorxiv.org/content/10.1101/2021.01.06.425392		Among the first selected minor variants in an in vitro evolution experiment for ACE2 binding.	False	C.37	C.37=True	de_escalated	14-Jun-2021		
F490S	g.T1469C	p.F490S			23031	S	S	MISSENSE	30	30	0						0	C=30	30	C	T	antibody epitope effects	Liu et al. (2020)	https://www.biorxiv.org/content/10.1101/2020.11.06.372037v2		Mutant screen in neutralization assay with a broad range of monoclonal antibodies shows resistence to mAb SARS2-32.	False	C.37	C.37=True	de_escalated	14-Jun-2021		
F490S	g.T1469C	p.F490S			23031	S	S	MISSENSE	30	30	0						0	C=30	30	C	T	antibody epitope effects	Sun et al. (2021)	https://www.biorxiv.org/content/10.1101/2021.03.22.436481v1		Complete loss of binding in ELISA by the variant against monoclonal antibody ab8	False	C.37	C.37=True	de_escalated	14-Jun-2021		
F490S	g.T1469C	p.F490S			23031	S	S	MISSENSE	30	30	0						0	C=30	30	C	T	convalescent plasma escape	Liu et al. (2021)	https://www.biorxiv.org/content/10.1101/2020.11.06.372037v2		Strong reduction in neutralization capability of all 4 convalescent sera tested (3 ablations).	False	C.37	C.37=True	de_escalated	14-Jun-2021		
F490S	g.T1469C	p.F490S			23031	S	S	MISSENSE	30	30	0						0	C=30	30	C	T	monoclonal antibody serial passage escape	Greaney et al. (2020)	https://doi.org/10.1016/j.chom.2020.11.007		Ranked mildly effective mutant against this position in the RBD for highly neutralizing COV2-2496 monoclonal antibody	False	C.37	C.37=True	de_escalated	14-Jun-2021		
F490S	g.T1469C	p.F490S			23031	S	S	MISSENSE	30	30	0						0	C=30	30	C	T	monoclonal antibody serial passage escape	Starr et al. (2021)	https://www.biorxiv.org/content/10.1101/2021.02.17.431683v1		Escape mutation against monoclonal antibody LY-CoV555 (antibody that forms the basis for Eli Lilly's bamlanivimab)	False	C.37	C.37=True	de_escalated	14-Jun-2021		
F490S	g.T1469C	p.F490S			23031	S	S	MISSENSE	30	30	0						0	C=30	30	C	T	monoclonal antibody serial passage escape	Wang et al. (2021)	https://www.biorxiv.org/content/10.1101/2021.01.15.426911v2		Class 2/3 mAb C603 modestly selected for the emergence of this mutation in vitro.	False	C.37	C.37=True	de_escalated	14-Jun-2021		
F490S	g.T1469C	p.F490S			23031	S	S	MISSENSE	30	30	0						0	C=30	30	C	T	pharmaceutical effectiveness	Rappazzo et al. (2021)	https://science.sciencemag.org/content/371/6531/823		Greater than 10-fold rediuction of binding effeiency vs wild type for mAb LY-CoV555.	False	C.37	C.37=True	de_escalated	14-Jun-2021		
F66F	g.C198T	p.F66F			28471	N	N	SILENT	30	30	0						29	T=1	1	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
F924F	g.C2772T	p.F924F			3037	ORF1ab	ORF1a	SILENT	30	30	0			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab		0	T=30	30	T	C						False	C.37	C.37=True	de_escalated	14-Jun-2021		
G214C	g.G640T	p.G214C			28913	N	N	MISSENSE	30	30	0						0	T=30	30	T	G						False	C.37	C.37=True	de_escalated	14-Jun-2021		
G243S	g.G727A	p.G243S			29000	N	N	MISSENSE	30	30	0						29	A=1	1	A	G						False	C.37	C.37=False	de_escalated	14-Jun-2021		
G3278S	g.G9832A	p.G3278S			10097	ORF1ab	ORF1a	MISSENSE	30	30	0			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab		0	A=30	30	A	G						False	C.37	C.37=True	de_escalated	14-Jun-2021		
G4729G	g.T14187C	p.G4729G			14451	ORF1ab	ORF1b	SILENT	30	30	0			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only		28	C=2	2	C	T						False	C.37	C.37=False	de_escalated	14-Jun-2021		
GT75VI	g.GTAC224_227TTAT	p.GT75VI			21747	S	S		30	30	0						0	TTACTTGGTTCCATGCTATACATGTCTCTGGGACCAATGTTAT=28	28	TTACTTGGTTCCATGCTATACATGTCTCTGGGACCAATGTTAT	TTACTTGGTTCCATGCTATACATGTCTCTGGGACCAATGGTAC						False	C.37	C.37=True	de_escalated	14-Jun-2021		
H2092Y	g.C6274T	p.H2092Y			6539	ORF1ab	ORF1a	MISSENSE	30	30	0			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab		18	T=12	12	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
I1276T	g.T3827C	p.I1276T			4092	ORF1ab	ORF1a	MISSENSE	30	30	0			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab		29	C=1	1	C	T						False	C.37	C.37=False	de_escalated	14-Jun-2021		
I168I	g.C504T	p.I168I			27026	M	M	SILENT	30	30	0						29	T=1	1	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
I3341V	g.A10021G	p.I3341V			10286	ORF1ab	ORF1a	MISSENSE	28	30	0			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab		27	G=1	1	G	A						False	C.37	C.37=False	de_escalated	14-Jun-2021		
I37T	g.T110C	p.I37T			25502	ORF3a	ORF3a	MISSENSE	30	30	0						29	C=1	1	C	T						False	C.37	C.37=False	de_escalated	14-Jun-2021		
I3T	g.T8C	p.I3T			27401	ORF7a	ORF7a	MISSENSE	30	30	0						28	C=2	2	C	T						False	C.37	C.37=False	de_escalated	14-Jun-2021		
I4048I	g.T12144C	p.I4048I			12409	ORF1ab	ORF1a	SILENT	30	30	0			nsp8	produced by both pp1a and pp1ab		29	C=1	1	C	T						False	C.37	C.37=False	de_escalated	14-Jun-2021		
I473I	g.C1419T	p.I473I			1684	ORF1ab	ORF1a	SILENT	30	30	0			nsp2	produced by both pp1a and pp1ab		29	T=1	1	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
I82V	g.A244G	p.I82V			26766	M	M	MISSENSE	30	30	0						8	G=22	22	G	A						False	C.37	C.37=False	de_escalated	14-Jun-2021		
K141_F143del	g.421_429delAAGTCATTT	p.K141_F143del			685	ORF1ab	ORF1a		30	30	0			leader protein	nsp1, produced by both pp1a and pp1ab		29	AG=1	1	AG	AAAGTCATTTG						False	C.37	C.37=False	de_escalated	14-Jun-2021		
K2067K	g.A6201G	p.K2067K			6466	ORF1ab	ORF1a	SILENT	30	30	0			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab		29	G=1	1	G	A						False	C.37	C.37=False	de_escalated	14-Jun-2021		
K3353R	g.A10058G	p.K3353R			10323	ORF1ab	ORF1a	MISSENSE	28	30	0			3C-like proteinase	nsp5A_3CLpro and nsp5B_3CLpro, main proteinase (Mpro), mediates cleavages downstream of nsp4. 3D structure of the SARSr-CoV homolog has been determined (Yang et al., 2003), produced by both pp1a and pp1ab		10	G=18	18	G	A						False	C.37	C.37=False	de_escalated	14-Jun-2021		
K444R	g.A1331G	p.K444R			22893	S	S	MISSENSE	30	30	0						29	G=1	1	G	A	convalescent plasma escape	Weisblum et al. (2020)	https://www.biorxiv.org/content/10.1101/2020.07.21.214759v1.full.pdf		Positive selection (up to 20% of supernatant sequences) under two rounds of COV-NY convalescent plasma passage, eliminated in rounds three and four	False	C.37	C.37=False	de_escalated	14-Jun-2021		
K444R	g.A1331G	p.K444R			22893	S	S	MISSENSE	30	30	0						29	G=1	1	G	A	monoclonal antibody serial passage escape	Dong et al. (2021)	https://www.biorxiv.org/content/10.1101/2021.01.27.428529v2		Identified in 6/20 replicates of recombinant VSV growth in the presence of mAb COV2-2130.	False	C.37	C.37=False	de_escalated	14-Jun-2021		
L1243L	g.C3727T	p.L1243L			3992	ORF1ab	ORF1a	SILENT	30	30	0			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab		29	T=1	1	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
L124L	g.C372T	p.L124L			26894	M	M	SILENT	30	30	0						0	T=30	30	T	C						False	C.37	C.37=True	de_escalated	14-Jun-2021		
L296L	g.C888T	p.L296L			22450	S	S	SILENT	29	30	0						28	T=1	1	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
L3198L	g.C9592T	p.L3198L			9857	ORF1ab	ORF1a	SILENT	30	30	0			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab		0	T=30	30	T	C						False	C.37	C.37=True	de_escalated	14-Jun-2021		
L3201P	g.T9602C	p.L3201P			9867	ORF1ab	ORF1a	MISSENSE	30	30	0			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab		0	C=30	30	C	T						False	C.37	C.37=True	de_escalated	14-Jun-2021		
L3606F	g.G10818T	p.L3606F			11083	ORF1ab	ORF1a	MISSENSE	30	30	0	mask	highly_homoplasic	nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab		29	T=1	1	T	G						False	C.37	C.37=False	de_escalated	14-Jun-2021		
L3935L	g.G11805T	p.L3935L			12070	ORF1ab	ORF1a	SILENT	30	30	0			nsp7	produced by both pp1a and pp1ab		29	T=1	1	T	G						False	C.37	C.37=False	de_escalated	14-Jun-2021		
L452Q	g.T1355A	p.L452Q			22917	S	S	MISSENSE	30	30	0						0	A=30	30	A	T	ACE2 receptor binding affinity	Starr et al. (2020)	https://doi.org/10.1016/j.cell.2020.08.012		Experimentally, ACE2 binding affinity increased 0.07 fold	False	C.37	C.37=True	de_escalated	14-Jun-2021		
L452Q	g.T1355A	p.L452Q			22917	S	S	MISSENSE	30	30	0						0	A=30	30	A	T	gene expression increase	Starr et al. (2020)	https://doi.org/10.1016/j.cell.2020.08.012		Experimentally, Spike gene expression increased 0.27 fold	False	C.37	C.37=True	de_escalated	14-Jun-2021		
M1014I	g.G3042T	p.M1014I			3307	ORF1ab	ORF1a	MISSENSE	30	30	0			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab		28	T=2	2	T	G						False	C.37	C.37=False	de_escalated	14-Jun-2021		
N4992N	g.C14976T	p.N4992N			15240	ORF1ab	ORF1b	SILENT	30	30	0			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only		29	T=1	1	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
N5020N	g.C15060T	p.N5020N			15324	ORF1ab	ORF1b	SILENT	30	30	0			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only		29	T=1	1	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
P13L	g.C38T	p.P13L			28311	N	N	MISSENSE	30	30	0						0	T=30	30	T	C	T cell evasion	de Silva et al. (2021)	https://www.biorxiv.org/content/10.1101/2021.04.08.438904v1		Variant causes complete loss of T cell line responsiveness to B*27:05-restricted CD8+ N epitope QRNAPRITF 1-17(2,13).	False	C.37	C.37=True	de_escalated	14-Jun-2021		
P13L	g.C38T	p.P13L			28311	N	N	MISSENSE	30	30	0						0	T=30	30	T	C	homoplasy	Borges et al. (2021)	https://www.biorxiv.org/content/10.1101/2021.05.19.444774v1		In experimental models of SARS-CoV-2 mutational evolution (without immune pressure), this mutation appears convergent. 	False	C.37	C.37=True	de_escalated	14-Jun-2021		
P2287S	g.C6859T	p.P2287S			7124	ORF1ab	ORF1a	MISSENSE	29	30	0			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab		0	T=29	29	T	C						False	C.37	C.37=True	de_escalated	14-Jun-2021		
P25P	g.C75T	p.P25P			21637	S	S	SILENT	30	30	0						29	T=1	1	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
P4058P	g.C12174T	p.P4058P			12439	ORF1ab	ORF1a	SILENT	30	30	0			nsp8	produced by both pp1a and pp1ab		29	T=1	1	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
P4715L	g.C14144T	p.P4715L			14408	ORF1ab	ORF1b	MISSENSE	30	30	0			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only		0	T=30	30	T	C						False	C.37	C.37=True	de_escalated	14-Jun-2021		
P521R	g.C1562G	p.P521R			23124	S	S	MISSENSE	30	30	0						29	G=1	1	G	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
Q644Q	g.A1932G	p.Q644Q			23494	S	S	SILENT	30	30	0						29	G=1	1	G	A						False	C.37	C.37=False	de_escalated	14-Jun-2021		
Q90X	g.C268T	p.Q90X			27661	ORF7a	ORF7a	NONSENSE	30	30	0						28	T=2	2	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
R2189R	g.A6567G	p.R2189R			6832	ORF1ab	ORF1a	SILENT	30	30	0			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab		29	G=1	1	G	A						False	C.37	C.37=False	de_escalated	14-Jun-2021		
R246_D253delinsN	g.737_757delGAAGTTATTTGACTCCTGGTG	p.R246_D253delinsN			22298	S	S		11	30	0						2	AA=9	9	AA	AGAAGTTATTTGACTCCTGGTGA						False	C.37	C.37=True	de_escalated	14-Jun-2021		
R398C	g.C1192T	p.R398C			1457	ORF1ab	ORF1a	MISSENSE	30	30	0			nsp2	produced by both pp1a and pp1ab		29	T=1	1	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
R4565C	g.C13693T	p.R4565C			13957	ORF1ab	ORF1b	MISSENSE	30	30	0			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only		29	T=1	1	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
R560H	g.G1679A	p.R560H			1944	ORF1ab	ORF1a	MISSENSE	30	30	0			nsp2	produced by both pp1a and pp1ab		28	A=2	2	A	G						False	C.37	C.37=False	de_escalated	14-Jun-2021		
RG203KR	g.GGG608_610AAC	p.RG203KR			28881	N	N		30	30	0						0	AAC=30	30	AAC	GGG						False	C.37	C.37=True	de_escalated	14-Jun-2021		
S46L	g.C137T	p.S46L			21699	S	S	MISSENSE	30	30	0						28	T=2	2	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
T10I	g.C29T	p.T10I			27230	ORF6	ORF6	MISSENSE	30	30	0						28	T=2	2	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
T1246I	g.C3737T	p.T1246I			4002	ORF1ab	ORF1a	MISSENSE	30	30	0			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab		0	T=30	30	T	C						False	C.37	C.37=True	de_escalated	14-Jun-2021		
T12A	g.A34G	p.T12A			299	ORF1ab	ORF1a	MISSENSE	30	30	0			leader protein	nsp1, produced by both pp1a and pp1ab		29	G=1	1	G	A						False	C.37	C.37=False	de_escalated	14-Jun-2021		
T19K	g.C56A	p.T19K			21618	S	S	MISSENSE	30	30	0						28	A=2	2	A	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
T2967I	g.C8900T	p.T2967I			9165	ORF1ab	ORF1a	MISSENSE	30	30	0			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab		29	T=1	1	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
T3255I	g.C9764T	p.T3255I			10029	ORF1ab	ORF1a	MISSENSE	30	30	0			nsp4	nsp4B_TM, contains transmembrane domain 2 (TM2), produced by both pp1a and pp1ab		0	T=30	30	T	C						False	C.37	C.37=True	de_escalated	14-Jun-2021		
T366I	g.C1097T	p.T366I			29370	N	N	MISSENSE	17	30	0						1	T=16	16	T	C						False	C.37	C.37=True	de_escalated	14-Jun-2021		
T4161I	g.C12482T	p.T4161I			12747	ORF1ab	ORF1a	MISSENSE	30	30	0			nsp9	ssRNA-binding protein, produced by both pp1a and pp1ab		28	T=2	2	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
T4477I	g.C13430T	p.T4477I			13694	ORF1ab	ORF1b	MISSENSE	30	30	0			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only		29	T=1	1	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
T547T	g.A1641G	p.T547T			23203	S	S	SILENT	30	30	0						28	G=2	2	G	A						False	C.37	C.37=False	de_escalated	14-Jun-2021		
T6131T	g.C18393T	p.T6131T			18657	ORF1ab	ORF1b	SILENT	30	30	0			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only		29	T=1	1	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
T63_T76delinsI	g.CTTGGTTCCATGCTATACATGTCTCTGGGACCAATGGTAC188_227T	p.T63_T76delinsI			21747	S	S		30	30	0						0	TTAT=2	2	TTAT	TTACTTGGTTCCATGCTATACATGTCTCTGGGACCAATGGTAC						False	C.37	C.37=False	de_escalated	14-Jun-2021		
T711A	g.A2131G	p.T711A			2396	ORF1ab	ORF1a	MISSENSE	30	30	0			nsp2	produced by both pp1a and pp1ab		29	G=1	1	G	A						False	C.37	C.37=False	de_escalated	14-Jun-2021		
T723T	g.C2169T	p.T723T			23731	S	S	SILENT	30	30	0						0	T=30	30	T	C						False	C.37	C.37=True	de_escalated	14-Jun-2021		
T859N	g.C2576A	p.T859N			24138	S	S	MISSENSE	30	30	0						0	A=30	30	A	C						False	C.37	C.37=True	de_escalated	14-Jun-2021		
V3721V	g.T11163A	p.V3721V			11428	ORF1ab	ORF1a	SILENT	30	30	0			nsp6	nsp6_TM, putative transmembrane domain, produced by both pp1a and pp1ab		28	A=2	2	A	T						False	C.37	C.37=False	de_escalated	14-Jun-2021		
V62F	g.G184T	p.V62F			26428	E	E	MISSENSE	30	30	0						29	T=1	1	T	G						False	C.37	C.37=False	de_escalated	14-Jun-2021		
V6384A	g.T19151C	p.V6384A			19415	ORF1ab	ORF1b	MISSENSE	30	30	0			3'-to-5' exonuclease	nsp14A2_ExoN and nsp14B_NMT, produced by pp1ab only		29	C=1	1	C	T						False	C.37	C.37=False	de_escalated	14-Jun-2021		
Y2262Y	g.C6786T	p.Y2262Y			7051	ORF1ab	ORF1a	SILENT	30	30	0			nsp3	former nsp1, conserved domains are: N-terminal acidic (Ac), predicted phosphoesterase, papain-like proteinase, Y-domain, transmembrane domain 1 (TM1), adenosine diphosphate-ribose 1''-phosphatase (ADRP), produced by both pp1a and pp1ab		28	T=2	2	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
Y4424Y	g.C13272T	p.Y4424Y			13536	ORF1ab	ORF1b	SILENT	30	30	0			RNA-dependent RNA polymerase	nsp12, NiRAN and RdRp, produced by pp1ab only		0	T=30	30	T	C						False	C.37	C.37=True	de_escalated	14-Jun-2021		
Y5541Y	g.C16623T	p.Y5541Y			16887	ORF1ab	ORF1b	SILENT	30	30	0	mask	highly_homoplasic	helicase	nsp13_ZBD, nsp13_TB, and nsp_HEL1core, zinc-binding domain (ZD), NTPase/helicase domain (HEL), RNA 5'-triphosphatase, produced by pp1ab only		26	T=4	4	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
g.A-3T	g.A-3T				28271	N	intergenic		30	30	0						0	T=30	30	T	A						False	C.37	C.37=True	de_escalated	14-Jun-2021		
g.ATTTTCA29725ATTTCA	g.ATTTTCA29725ATTTCA				29725	intergenic	intergenic		30	30	0						28	ATTTCA=2	2	ATTTCA	ATTTTCA						False	C.37	C.37=False	de_escalated	14-Jun-2021		
g.C-25T	g.C-25T				241	ORF1ab	intergenic		30	30	0						0	T=30	30	T	C						False	C.37	C.37=True	de_escalated	14-Jun-2021		
g.C29750T	g.C29750T				29750	intergenic	intergenic		30	30	0						28	T=2	2	T	C						False	C.37	C.37=False	de_escalated	14-Jun-2021		
